Frequency, characteristics, predictors and treatment of relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).

Autor: Rempe T; Department of Neurology, College of Medicine, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA. Electronic address: torge.rempe@neurology.ufl.edu., Rodriguez E; Department of Neurology, College of Medicine, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA., Elfasi A; Department of Neurology, College of Medicine, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA., Alkabie S; Department of Neurology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, NY 10075, USA., Perero MM; Department of Neurology, College of Medicine, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA., Castrodad-Molina R; Maxine Mesinger Multiple Sclerosis Comprehensive Care Center, Department of Neurology, Baylor College of Medicine, 7200 Cambridge Street, 9th floor, Houston, TX, 77030, USA., Cuascut FX; Maxine Mesinger Multiple Sclerosis Comprehensive Care Center, Department of Neurology, Baylor College of Medicine, 7200 Cambridge Street, 9th floor, Houston, TX, 77030, USA., Hutton GJ; Maxine Mesinger Multiple Sclerosis Comprehensive Care Center, Department of Neurology, Baylor College of Medicine, 7200 Cambridge Street, 9th floor, Houston, TX, 77030, USA., Kinkel R; Department of Neurosciences, University of California San Diego, School of Medicine, 9500 Gilman Drive, La Jolla, CA, 92093, USA., Graves J; Department of Neurosciences, University of California San Diego, School of Medicine, 9500 Gilman Drive, La Jolla, CA, 92093, USA.

Publikováno v: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Jul; Vol. 87, pp. 105672. Date of Electronic Publication: 2024 May 10.

Ocrelizumab B-cell repopulation-guided extended interval dosing versus standard dosing - similar clinical efficacy with decreased immunoglobulin M deficiency rates.

Autor: Rempe T; Department of Neurology, College of Medicine, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA; Department of Neurosciences, School of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA. Electronic address: torge.rempe@neurology.ufl.edu., Elfasi A; Department of Neurology, College of Medicine, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA., Rodriguez E; Department of Neurology, College of Medicine, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA., Vasquez M; Department of Neurology, College of Medicine, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610, USA., Graves J; Department of Neurosciences, School of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA., Kinkel R; Department of Neurosciences, School of Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA.

Publikováno v: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2023 Nov; Vol. 79, pp. 105028. Date of Electronic Publication: 2023 Sep 24.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

MOG-IgG1 and co-existence of neuronal autoantibodies.

Autor: Kunchok A; Department of Neurology, Mayo Clinic, Rochester, MN, USA/Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA/Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA., Flanagan EP; Department of Neurology, Mayo Clinic, Rochester, MN, USA/Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA/Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA., Krecke KN; Department of Radiology, Mayo Clinic, Rochester, MN, USA., Chen JJ; Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA/Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA/Department of Ophthalmology, Mayo Clinic, Rochester, MN, USA., Caceres JA; Department of Neurology, John Hopkins University School of Medicine, Baltimore, MD, USA., Dominick J; Division of Neurology, Sharp Rees-Stealy Medical Group, San Diego, CA, USA., Ferguson I; Department of Rheumatology, Yale University School of Medicine, New Haven, CT, USA., Kinkel R; Department of Neurology, University of San Diego, San Diego, CA, USA., Probasco JC; Department of Neurology, John Hopkins University School of Medicine, Baltimore, MD, USA., Ruvalcaba M; Department of Neurology, UC Davis Medical Center (UCDMC), Sacramento, CA, USA., Santoro JD; Division of Neurology, Children's Hospital Los Angeles, Los Angeles, CA, USA/Department of Neurology, Keck School of Medicine at University of Southern California, Los Angeles, CA, USA., Sieloff K; Department of Neurology, University of Michigan, Ann Arbor, MI, USA., Timothy J; Department of Neurology, Wellspan Pediatric Neurology, Manchester, PA, USA., Weinshenker BG; Department of Neurology, Mayo Clinic, Rochester, MN, USA/Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA., McKeon A; Department of Neurology, Mayo Clinic, Rochester, MN, USA/Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA/Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA., Pittock SJ; Department of Neurology, Mayo Clinic, Rochester, MN, USA/Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA/Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2021 Jul; Vol. 27 (8), pp. 1175-1186. Date of Electronic Publication: 2020 Sep 10.